Moderna on Thursday announced that an experimental cancer vaccine it is developing with Merck — when combined with the latter’s Keytruda immunotherapy — has been proven in a clinical trial to cut the ...
Stocks of COVID-19 vaccine makers take a dive following Washington Post report, while Moderna stresses multiple agencies have backed their safety Stocks of COVID vaccine makers dropped after the ...
Vaccine makers' stocks surged on Tuesday after the US reported its first bird flu death. Moderna, Novavax, and CureVac saw double-digit gains, while Pfizer and GSK also rose. The drugmakers have ...
Hosted on MSN
Pfizer, Moderna shares plunge on report that Trump officials plan to link 25 child deaths to COVID vaccine
Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively, Friday after a report that the Trump administration plans to link the deaths of 25 children to COVID vaccines. Trump health officials ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Shares of Moderna Inc. fell ...
Shares of ModernaMRNA and other vaccine stocks tumbled Monday after a Food and Drug Administration director suggested Covid shots killed at least 10 children between 2021 and 2024. Now, Vinay Prasad, ...
Shares of COVID-19 vaccine makers Pfizer Inc (NYSE:PFE), BioNTech SE ADR (NASDAQ:BNTX) and Moderna Inc (NASDAQ:MRNA) are trading lower Friday following a Washington Post report that Trump ...
A former Senior Publishing Editor on the Dow Jones Newswires team at The Wall Street Journal, Aaron earned a Bachelor's degree in Economics from the University of Michigan and a Master's in Journalism ...
Moderna stock (MRNA) fell over 9% on Wednesday, forfeiting most of its gains from Tuesday's session during a volatile week for the stock seen after the first reported bird flu death in the US, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback